[_ES1] 英語口演1
血液臨床

[ES1-1-1] 日本における小児急性リンパ性白血病の寛解導入療法中死亡について
Induction death of children with acute lymphoblastic leukemia in Japan

Shunsuke Nakagawa¹, Yasuhiro Okamoto¹, Toshihiko Imamura², Chihaya Imai³, Motohiro Kato⁴, Yoshifumi Kawano¹, Yasuto Shimomura⁵, Arata Watanabe⁶, Atsushi Kikuta⁷, Akiko Saito⁸, Keizo Horibe⁸, Atsushi Manabe⁹, Akira Ohara¹⁰, Katsuyoshi Koh¹¹ (1.Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 2.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.Department of Pediatrics, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan, 4.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 5.Department of Pediatrics, Aichi Medical School of Medicine, Aichi, Japan, 6.Department of Pediatrics, Nakadori General Hospital, Akita, Japan, 7.Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan, 8.Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan, 9.Department of Pediatrics, St Luke’s International Hospital, Tokyo, Japan, 10.Department of Pediatrics, Toho University Medical Center, Omori Hospital, Tokyo, Japan, 11.Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan)